TrialClinical cancer research : an official journal of the American Association for Cancer Research2018

Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study.

Leora Horn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.